Two new drugs used for preventing blood clot formation could result in improved outcomes in the treatment for heart diseases. According to the researchers, the drug can reduce rate of repeat heart attacks, as compared to bivalirudin which is more expensive. The results of the HEAT-PPCI trial suggest that systematic use of heparin rather than bivalirudin after primary percutaneous coronary intervention (PPCI) - the most commonly used treatment for ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment